Quick verdict: CCEP vs CL in 2026

In the current CCEP vs CL stock comparison 2026, Coca-Cola Europacific Partners PLC (CCEP) generally holds the overall edge, demonstrating stronger growth momentum, significantly more attractive valuation metrics, and a more favorable outlook from analysts. While Colgate-Palmolive Company (CL) showcases superior profitability margins, CCEP leads in revenue growth, free cash flow yield, and has considerably less debt, making it appear more compelling across several key fundamental and valuation indicators. Not investment advice.

CCEP vs CL: key metrics side by side

Full side-by-side comparison of CCEP and CL across valuation, profitability, growth and analyst sentiment. Data updated 2026-05-07.

CCEP vs CL valuation comparison

When evaluating CCEP vs CL fundamentals and valuation, Coca-Cola Europacific Partners PLC (CCEP) currently presents a more attractive valuation profile. CCEP trades at a P/E ratio of 18.46x, which is significantly lower than Colgate-Palmolive Company’s (CL) P/E ratio of 33.53x. This suggests that investors are paying less for CCEP’s earnings compared to CL’s, potentially indicating CCEP is undervalued relative to its peer on an earnings basis. The difference is even more stark when looking at the Price-to-Book (P/B) ratio, where CCEP stands at 4.57x against CL’s extraordinarily high 482.54x, highlighting a substantial disparity in how the market values their respective book assets.

Furthermore, the Discounted Cash Flow (DCF) models indicate a greater potential upside for CCEP. Its DCF valuation suggests a potential upside of +49.5% from its current price of $93.9643, reaching an estimated fair value of $140.52. In contrast, CL’s DCF valuation projects an upside of +33.1% from its price of $87.21 to a fair value of $116.11. This suggests that CCEP is perceived to have more intrinsic value yet to be realized in its stock price, making it appear cheaper than CL based on future cash flow expectations. Investors seeking value in the consumer defensive sector might find CCEP’s valuation metrics more appealing.

CCEP vs CL growth comparison

In terms of growth, Coca-Cola Europacific Partners PLC (CCEP) demonstrates stronger momentum compared to Colgate-Palmolive Company (CL). CCEP reported a year-over-year revenue growth of +2.3%, outpacing CL’s +1.4% revenue growth. While both are established players in the consumer defensive sector, CCEP’s slightly higher growth rate suggests a more dynamic top-line expansion. Both companies operate in mature markets, making even small differences in revenue growth significant indicators of market share gains or effective product innovation.

Although CCEP shows better revenue growth, CL holds an edge in profitability margins, which can influence future earnings growth. CL boasts a higher net margin of 10.04% and an EBITDA margin of 18.84% compared to CCEP’s net margin of 9.29% and EBITDA margin of 16.39%. This implies that while CCEP is growing revenue faster, CL is more efficient at converting revenue into profit. However, CCEP’s higher Free Cash Flow (FCF) yield of 6.02% versus CL’s 5.38% suggests CCEP is generating more cash relative to its market capitalization, which can be reinvested for future growth or returned to shareholders.

CCEP vs CL profitability

When analyzing CCEP vs CL profitability, Colgate-Palmolive Company (CL) generally exhibits stronger margin performance. CL recorded a net margin of 10.04%, slightly higher than CCEP’s 9.29%. This indicates that for every dollar of revenue, CL retains a larger portion as net income. Additionally, CL’s EBITDA margin stands at 18.84%, outperforming CCEP’s 16.39%. These higher margins suggest that CL manages its operational costs and expenses more efficiently than CCEP, which is a significant factor for long-term financial health and shareholder returns in the consumer defensive industry.

However, a closer look at the cash generation capability reveals CCEP’s strength in Free Cash Flow (FCF) yield. CCEP’s FCF yield of 6.02% is superior to CL’s 5.38%, indicating that CCEP generates more cash flow relative to its enterprise value. This strong FCF generation is crucial for funding operations, reducing debt, and returning capital to shareholders. Both companies show “N/A%” for Return on Equity (ROE) in the provided data, which prevents a direct comparison on this specific metric. Despite CL’s better net and EBITDA margins, CCEP’s higher FCF yield suggests it is effective at generating tangible cash, which can be a key driver for investor interest.

Analyst ratings: CCEP vs CL

Analyst sentiment clearly favors Coca-Cola Europacific Partners PLC (CCEP) over Colgate-Palmolive Company (CL) based on current ratings and price targets. Of the 28 analysts covering CCEP, a substantial 53.6% recommend a “Buy,” leading to a consensus rating of “Buy” for the stock. Their average price target for CCEP is $110.6, which implies a considerable upside potential of +17.7% from its current price of $93.9643. This strong endorsement from a majority of analysts suggests confidence in CCEP’s future performance and valuation.

In contrast, Colgate-Palmolive Company (CL) receives a less enthusiastic reception from the analyst community. Out of 45 analysts covering CL, only 42.2% have a “Buy” rating, resulting in a broader “Hold” consensus for the stock. The average price target set by these analysts is $94.9, representing a more modest upside of +8.8% from its current price of $87.21. The difference in buy ratings and target price upsides indicates that analysts perceive CCEP to have greater growth potential and a more attractive risk-reward profile compared to CL in the current market environment.

Should I buy CCEP or CL stock in 2026?

When considering should I buy CCEP or CL stock in 2026, growth investors might lean towards Coca-Cola Europacific Partners PLC (CCEP). CCEP exhibits a higher revenue growth rate of +2.3% compared to CL’s +1.4%, indicating stronger top-line momentum. Additionally, the higher Free Cash Flow yield of 6.02% for CCEP suggests robust cash generation that can fuel future expansion and innovation. The analyst consensus of “Buy” with a significant price target upside of +17.7% further reinforces the growth narrative for CCEP in the coming year.

For value investors focused on ccep vs cl fundamentals and valuation, CCEP presents a more compelling case. With a P/E ratio of 18.46x, CCEP is significantly cheaper than CL’s 33.53x, suggesting it trades at a discount relative to its earnings. The P/B ratio comparison is even more striking, with CCEP at 4.57x against CL’s 482.54x, highlighting CCEP’s potentially undervalued assets. The Discounted Cash Flow (DCF) analysis also points to a substantial +49.5% upside for CCEP, exceeding CL’s +33.1% upside, making CCEP an attractive prospect for those seeking undervalued opportunities.

For income-focused investors, the choice between CCEP and CL is less distinct, as both companies offer a modest and identical dividend yield of 0.02%. This indicates that neither stock is currently a standout choice primarily for dividend income. While both operate in stable consumer defensive sectors, investors prioritizing significant dividend payouts might need to look elsewhere. Overall, CCEP appears to have a more favorable outlook for both growth and value investors based on the provided metrics. This is not investment advice; always conduct your own thorough research.

More CCEP and CL comparisons

CCEP full stock analysis · CL full stock analysis · All stock comparisons

FAQ: CCEP vs CL